REVIEW
Published on 28 Sep 2026
Breaking the ERK1/2 negative feedback loop: avoiding reactivation and acquisition of resistance by ERK1/2 to anti-cancer agents
doi 10.3389/fonc.2026.1948976
- 480 views
Articles
MINI REVIEW
Published on 24 Aug 2026
KRAS mutations as architects of the tumor immune microenvironment: implications for combination therapies
doi 10.3389/fonc.2026.1933939
- 989 views
SYSTEMATIC REVIEW
Published on 10 Jul 2026
KRAS G12C inhibitors in KRASG12C-mutated solid tumors: an immunologically informed systematic review and reconstructed individual patient data meta-analysis
doi 10.3389/fimmu.2026.1848431
- 1,521 views
- 1 citation
BRIEF RESEARCH REPORT
Published on 29 Jun 2026
GSDMA deficiency impairs cutaneous squamous cell carcinoma growth
doi 10.3389/fonc.2026.1855268
- 1,060 views
MINI REVIEW
Published on 11 Feb 2026
Lung adenocarcinoma with KRAS-Q61H: clinicopathologic features, diagnostics, and the evolving treatment landscape
doi 10.3389/fonc.2026.1771549
- 3,038 views
ORIGINAL RESEARCH
Published on 28 Jan 2026
Antitumor effects of LPM5140276 and its potential combination with SHP2 inhibition in KRASG12D-mutant cancer
doi 10.3389/fphar.2025.1554356
- 1,629 views
- 2 citations
ORIGINAL RESEARCH
Accepted on 20 Aug 2026
N-WASP deficiency enhances oncogenic KRAS-mediated lung adenocarcinoma progression in mice
- 445 views
